The impact of education on the benefits of cognitive-behavioral therapy on improving the quality of life of patients after breast cancer treatment
DOI:
https://doi.org/10.12775/JEHS.2023.13.03.006Keywords
breast cancer treatment, quality of life, cognitive-behavioral therapyAbstract
Introduction: Treatment of breast cancer may be associated with the subsequent occurrence of many side effects, which may have a significant negative impact on the quality of life of patients after treatment. Such patients may experience bothersome menopausal symptoms, persistent pain, insomnia and depressed mood. The most common treatment to combat the above symptoms is pharmacotherapy, which in turn could also be associated with additional side effects. Cognitive-behavioral therapy can be an effective alternative to pharmacological treatment as well as an effective complementary treatment.
Aim of the study: The aim of the study is to summarize the current state of knowledge on the impact of cognitive-behavioral therapy on improving quality of life of patients after breast cancer treatment.
Material and methods: The literature available in the Pubmed database was reviewed using key phrases.
Results: Cognitive-behavioral therapy used in patients after breast cancer treatment brings good results in combating symptoms such as anxiety, depression, menopausal symptoms, persistent, chronic pain or insomnia resulting from the above symptoms. With the above therapy, you can correct not only the severity, but above all the perception of all of the above-mentioned symptoms, which is of key importance in the context of maintaining the quality of life as before the start of treatment.
Conclusion: The development of patient education on the benefits of using cognitive behavioral therapy as an adjuvant treatment after breast cancer treatment may have a beneficial effect on improving the quality of life in these patients.
References
Costa AR, Fontes F, Pereira S, et al. Impact of breast cancer treatments on sleep disturbances - a systematic review. Breast. 2014;236:697–709. 10.1016/j.breast.2014.09.003
Moore TA, Berger AM, Dizona P.. Sleep aid use during and following breast cancer adjuvant chemotherapy. Psychooncology. 2011;203:321–325. 10.1002/pon.1756
Mitchell MD, Gehrman P, Perlis M, et al. Comparative effectiveness of cognitive behavioral therapy for insomnia: A systematic review. BMC Fam Pract. 2012;13:40. 10.1186/1471-2296-13-40
Jonathan S., Berek, Emil Novak, Ginekologia tom 3, Lippincott Williams & Wilkins 2008, 1441-1445
Vera Atema, Marieke van Leeuwen, Jacobien M. Kieffer, Hester S.A. Oldenburg, Marc van Beurden, Myra S. Hunter, Neil K. Aaronson. Internet-based cognitive behavioral therapy aimed at alleviating treatment-induced menopausal symptoms in breast cancer survivors: Moderators and mediators of treatment effects, Maturitas 2019; https://doi.org/10.1016/j.maturitas.2019.09.007
Meretoja TJ, Leidenius MHK, Tasmuth T, Sipila R, Kalso E. Pain at 12 months after surgery for breast cancer. J Am Med Assoc 2014;311:90e2.
Mejdahl MK, Andersen KG, Gartner R, Kroman N, Kehlet H. Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study. BMJ 2013;346:f1865.
Edwards RR, Dworkin RH, Sullivan MD, Turk DC, Wasan AD. The role of psy- chosocial processes in the development and maintenance of chronic pain. J Pain 2016;17:T70e92.
Sturgeon JA, Zautra AJ. Psychological resilience, pain catastrophizing, and positive emotions: perspectives on comprehensive modeling of individual pain adaptation. Curr Pain Headache Rep 2013;17:317
Vlaeyen JW, Linton SJ. Fear-avoidance model of chronic musculoskeletal pain: 12 years on. Pain 2012;153:1144e7.
Vlaeyen JW, Crombez G, Linton SJ. The fear-avoidance model of pain. Pain 2016;157:1588e9.
Reetta Sipilä, Eija Kalso, Jörn Lötsch. Machine-learned identification of psychological subgroups with relation to pain interference in patients after breast cancer treatments, Elsevier 2020; https://www.thebreastonline.com/action/showPdf?pii=S0960-9776%2820%2930057-6#page9
Kaunisto MA, Jokela R, Tallgren M, Kambur O, Tikkanen E, Tasmuth T, et al. Pain in 1,000 women treated for breast cancer: a prospective study of pain sensitivity and postoperative pain. Anesthesiology 2013;119:1410e21.
Mustonen L, Aho T, Harno H, Sipil€a R, Meretoja T, Kalso E. What makes sur- gical nerve injury painful? A 4-9 year follow-up of patients with inter- costobrachial nerve resection in women treated for breast cancer. 2018. Pain.
Wright LJ, Zautra AJ, Going S. Adaptation to early knee osteoarthritis: the role of risk, resilience, and disease severity on pain and physical functioning. Ann Behav Med 2008;36:70e80.
Goubert L, Trompetter H. Towards a science and practice of resilience in the face of pain. Eur J Pain 2017;21:1301e15.
Hirsh JB, Deyoung CG, Peterson JB. Metatraits of the Big Five differentially predict engagement and restraint of behavior. J Pers 2009;77:1085e102.
Howell D, Oliver TK, Keller-Olaman S, et al. Sleep disturbance in adults with cancer: A systematic review of evidence for best practices in assessment and management for clinical practice. Ann Oncol. 2014;254:791–800. 10.1093/annonc/mdt506
Minton O, Alexander S, Stone PC.. Identification of factors associated with cancer related fatigue syndrome in disease-free breast cancer patients after completing primary treatment. Breast Cancer Res Treat. 2012;1362:513–520. 10.1007/s10549-012-2284-1
Ancoli-Israel S, Moore PJ, Jones V.. The relationship between fatigue and sleep in cancer patients: A review. Eur J Cancer Care (Engl). 2001;104:245–255. 10.1046/j.1365-2354.2001.00263.x
Trudel-Fitzgerald C, Zhou ES, Poole EM, et al. Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses' Health Study. Br J Cancer. 2017;1169:1239–1246.
Marinac CR, Nelson SH, Flatt SW, et al. Sleep duration and breast cancer prognosis: Perspectives from the Women's Healthy Eating and Living Study. Breast Cancer Res Treat. 2017;1623:581–589. 10.1007/s10549-017-4140-9
Moore TA, Berger AM, Dizona P.. Sleep aid use during and following breast cancer adjuvant chemotherapy. Psychooncology. 2011;203:321–325. 10.1002/pon.1756
Omvik S, Pallesen S, Bjorvatn B, et al. Patient characteristics and predictors of sleep medication use. Int Clin Psychopharmacol. 2010;252:91–100. 10.1097/YIC.0b013e328334e5e6
Riemann D, Perlis ML.. The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009;133:205–214. 10.1016/j.smrv.2008.06.001
Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;1652:125–133. 10.7326/M15-2175
Robert Zachariae, Ali Amidi, Malene F Damholdt, Cecilie D R Clausen, Jesper Dahlgaard, Holly Lord, Frances P Thorndike, Lee M Ritterband. Internet-Delivered Cognitive-Behavioral Therapy for Insomnia in Breast Cancer Survivors: A Randomized Controlled Trial, Journal of the National Cancer Institute 2018; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093474/#djx293-B1
Ascensión Bellver-Pérez, Cristina Peris-Juan and Ana Santaballa-Beltrán. Effectiveness of therapy group in women with localized breast cancer, International Journal of Clinical and Health Psychology 2019; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517697/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Magdalena Majcher, Monika Majcher, Kamila Świercz, Dominika Górska, Aleksandra Karwańska, Agata Pikulicka, Małgorzata Sierpień, Piotr Brzychczy, Aleksandra Kulbat, Mateusz Kulbat
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 399
Number of citations: 0